Back to
FMR LLC
QNCX
Showing 4 of 19 quarters
Position history for
FMR LLC's holdings in QUINCE THERAPEUTICS INC
No. FMR exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 70 shares worth $235. FMR already held QNCX in its Q3 2019 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$67
Total Shares Change
-50
Quarter-by-Quarter History